Suven Life Sciences Ltd.

NSE: SUVEN | BSE: 530239 | ISIN: INE495B01038 | Industry: Healthcare Services
|
133.3100 -2.68 (-1.97%)
NSE Apr 28, 2025 15:31 PM
Volume: 306.9K
 

133.31
-1.97%

Suven LifeSciences has seen a strong Q3 - albeit tempered from the Q2 this year - that will help the company end FY17 on a high note. The company declared a Q3 jump in net profit jump of 34.3% compared to the same quarter last year, with operating margins year on year helped by lower expenses and finance costs.

QoQ performance for the company saw net profits fall 8.6%, although for the overall nine month period Suven's incomes are up 9.98% and profits up 32.77% compared to the previous year. The company has secured 5 product patents in neurodegenerative treatments over the financial year, including Alzheimer's treatments. 

Suven Life Sciences Ltd. has gained 16.18% in the last 1 Month
More from Suven Life Sciences Ltd.
Recommended